Late Breaking News
ANN ARBOR, MI — How does less-than-adequate bowel preparation for colonoscopy affect adenoma miss rates and future screening recommendations for average-risk patients?
What is the Survival Benefit of PSA Testing?
The question of how and when prostate-specific antigen (PSA) screening for prostate cancer should be used, if at all, is being debated across the medical establishment. Those arguments — and any resolution — will have a significant effect on the VA, which diagnoses more than 12,000 new cases of prostate cancer each year.
DUBLIN, OH - The U.S. Food and Drug Administration recently approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, the first new drug used for lymph node mapping to be approved in more than 30 years.
Prostate cancer is the most common cancer among men in the U.S. (Siegel 2012) with more than 12,000 new diagnoses per year among veterans in Veterans Health Administration (Zullig 2012).
WAYNE, NJ - Tthe U.S. Food and Drug Administration (FDA) has approved Bayer's Stivarga (regorafenib) tablets to treat patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate, according to Bayer HealthCare and Onyx Pharmaceuticals, Inc.
SAN FRANCISCO - The FDA has approved Kadcyla (ado-trastuzumab emtansine or T-DM1) for the treatment of people with HER2-positive metastatic breast cancer (mBC) who have received prior treatment with Herceptin (trastuzumab) and a taxane chemotherapy.
Bethesda MD - Walter Reed National Military Medical Center honored the late Rep. John P. Murtha last month by renaming its comprehensive cancer center in memory of the Pennsylvania congressman.
MINNEAPOLIS — New research out of the Minneapolis VAMC finds that radical prostatectomy does not significantly reduce the risk of death in prostate cancer patients, when compared to observation over more than a decade. While that study confirms other major research on the topic, the controversy about how to treat early-stage prostate cancer continues.
Please read this article and participate in this month's online opinion poll whether radical prostatectomy is overused in early stage prostate cancer at the VA?
When is a cancer patient too old to benefit from a surgical procedure? An answer to that question has been hard to find. Now, researchers from the Minneapolis VAMC are providing data and guidelines to help physicians and surgeons determine optimal treatments for colon and lung cancers.
Controversy continues about when and for whom prostate-specific antigen (PSA) screening makes sense. PSA testing often is on lists of “excessive” medical procedures, but primary-care physicians are uncomfortable doing no screening for the common cancer. Two VA clinicians who have researched extensively in the area offer practical advice.
Most Popular Stories
- Many Healthcare Providers Lose VA Retention Bonuses
- Federal Medicine Organizational Meetings — Tarred with the Same Brush?
- Despite Formulary, High-Cost Diabetes Drug Use Varies Widely Across VA Facilities
- Report Says Administration Faces Hard Choices For Veterans Programs
- Physician Overcomes TBI to Return to Active-Duty Medicine
Join Our E-Mail List